Tag Archives: Raju Prasad
Selecta Biosciences (SELB) Receives a Buy from William Blair
William Blair analyst Raju Prasad maintained a Buy rating on Selecta Biosciences (SELB – Research Report) today. The company’s shares closed last Tuesday at $2.56. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 12.5% and
Precision BioSciences (DTIL) Receives a Buy from William Blair
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Precision BioSciences (DTIL – Research Report). The company’s shares closed last Monday at $5.59, close to its 52-week low of $4.46. According to TipRanks.com, Prasad
Poseida Therapeutics (PSTX) Receives a Buy from William Blair
William Blair analyst Raju Prasad maintained a Buy rating on Poseida Therapeutics (PSTX – Research Report) today. The company’s shares closed last Wednesday at $9.80. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 14.0% and
William Blair Sticks to Their Hold Rating for Bluebird Bio (BLUE)
William Blair analyst Raju Prasad maintained a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed last Friday at $56.75. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 15.6% and
William Blair Maintains Their Buy Rating on Assembly Biosciences (ASMB)
William Blair analyst Raju Prasad maintained a Buy rating on Assembly Biosciences (ASMB – Research Report) today. The company’s shares closed last Thursday at $20.85. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 15.4% and
Poseida Therapeutics (PSTX) Has a New Rating from William Blair
In a report released today, Raju Prasad from William Blair initiated coverage with a Buy rating on Poseida Therapeutics (PSTX – Research Report). The company’s shares closed last Thursday at $9.11, close to its 52-week low of $8.38. According to
